Hepatitis delta virus (HDV) is a single-stranded RNA virus that encodes two viral nucleocapsid proteins named small and large form hepatitis delta antigen (S-HDAg and L-HDAg). The S-HDAg is essential for viral RNA replication while the L-HDAg is required for viral assembly. In this study, we demonstrated that HDAg are acetylated proteins. Metabolic labeling with [ 3 H]acetate revealed that both forms of HDAg could be acetylated in vivo. The histone acetyltransferase (HAT) domain of cellular acetyltransferase p300 could acetylate the fulllength and the N-terminal 88 amino acids of S-HDAg in vitro. By mass spectrometric analysis of the modified protein, Lys-72 of S-HDAg was identified as one of the acetylation sites. Substitution of Lys-72 to Arg caused the mutant S-HDAg to redistribute from the nucleus to the cytoplasm. The mutant reduced viral RNA accumulation and resulted in the earlier appearance of L-HDAg. These results demonstrated that HDAg is an acetylated protein and mutation of HDAg at Lys-72 modulates HDAg subcellular localization and may participate in viral RNA nucleocytoplasmic shuttling and replication. D
Introduction
Hepatitis delta virus (HDV) contains a 1.7-kb circular RNA genome. It is a satellite virus that requires its helper virus, hepatitis B virus (HBV), to supply the envelope proteins for viral assembly (Bonino et al., 1984 (Bonino et al., , 1986 Rizzetto et al., 1980) . However, HDV is capable of replicating its genome in the absence of HBV (Kuo et al., 1989) . A double rolling-circle mechanism has been proposed for HDV RNA replication (Branch and Robertson, 1984; Lai, 1995) . Host cellular transcription machinery is believed to be responsible for this process (Chang and Taylor, 2002; Modahl et al., 2000; Moraleda and Taylor, 2001) .
There are two viral proteins encoded by HDV named large and small delta antigens (HDAg), respectively. These two proteins are identical in sequence, except that the large HDAg (L-HDAg) contains an additional 19 amino acids at its C-terminus resulting from RNA editing of the termination codon (Bergmann and Gerin, 1986; Casey et al., 1992; Jilbert et al., 1991) . Although the similarity in amino acid sequences, each protein has distinct functions. The small HDAg (S-HDAg) is essential for HDV replication, while the L-HDAg is necessary for virion assembly (Chang et al., 1991; Taylor et al., 1991) . Both HDAg have several functional domains. A coiled-coil domain in the N-terminus is responsible for HDAg oligomerization (Lazinski and Taylor, 1993; Zuccola et al., 1998) . A nuclear localization signal (NLS) and an RNA-binding domain in the middle portion of HDAg mediate the nuclear import of HDV RNA (Chang et al., 1988; Chao et al., 1991; Chou et al., 1998; Lin et al., 1990; . The additional 19 amino acid stretch of L-HDAg contains an isoprenylation site important for viral assembly (Hwang and Lai, 1993; Lee et al., 1994 ) and a sequence functioning as nuclear export signal .
HDV replication takes place within the nucleus (Rizzetto et al., 1977; Wu et al., 1992) . A kinetic study of newly synthesized HDV RNA discovered a transient phase of shuttling viral genomic RNA into the cytoplasm and then reimporting into the nucleus . A heterokaryon analysis also supported the point of HDV RNA shuttling between the cytoplasm and the nucleus (Tavanez et al., 2002) . These results indicate that nucleocytoplasmic shuttling is important in the HDV life cycle. However, the signal that regulates the shuttling of HDAg and HDV RNA has not been identified. Posttranslational modifications have been demonstrated to participate in modulating functions and properties of several proteins (Schwoebel and Moore, 2000; van der Geer, 2002) . HDAg had been identified to be a phosphorylated protein (Chang et al., 1988; Chen et al., 2002; Mu et al., 1999; Yeh et al., 1996) . Phosphorylation at serine residue 177 of HDAg affects HDV viral replication (Mu et al., 2001) but does not change the subcellular localization of HDAg (data not shown). Another posttranslational modification that modulates protein functions is acetylation. Several cellular transcription factors have been shown to change their nucleoplasmic localization when varying their status of acetylation. For example, acetylation is crucial for nuclear accumulation of HNF4 (hepatocyte nuclear factor-4) (Soutoglou et al., 2000) and MHC II (major histocompatibility class II) trans-activator CIITA (Spilianakis et al., 2000) . In addition, reversible acetylation also controls the subcellular localization of NF-nB .
In this study, we demonstrated that HDAg was acetylated both in vivo and in vitro. An acetylation site of S-HDAg was identified at Lys-72. A Lys to Arg substitution at this site (K72R) resulted in reduction of HDV genomic RNA Fig. 1 . Acetylation of HDAg in vivo. (Panel A) H7-SHDAg cells that stably expressed S-HDAg (lane 1) or the parental HuH-7 cells (lane 2) were labeled with [ 3 H]sodium acetate for 90 min. Extracts were subjected to immunoprecipitation with an anti-HDAg antibody and the immunopurified proteins were analyzed by SDS-PAGE and autoradiography (see Materials and methods). (Panel B) S-HDAg (lane 1) and L-HDAg (lane 2) were expressed in HuH-7 cells by transient transfection and the in vivo acetylation assay was performed as described in panel A. The exposure time of gel containing acetylated L-HDAg was longer than that of the S-HDAg by 2-fold. (Panels C and D) One-thirtieth of extracts from radiolabeled cells was subjected to SDS-PAGE followed by Western blot analysis with an anti-HDAg polycloal antibody (see Materials and methods). accumulation as well as cytoplasmic accumulation of S-HDAg and earlier appearance of L-HDAg. Thus, this study suggests that HDAg is an acetylated protein and the acetylation of HDAg may modulate its nucleoplasmic shuttling as well as HDV life cycle.
Results

Both HDAg are acetylated in vivo
We first examined whether HDAg could be acetylated in vivo. S-HDAg-producing cells (H7-SHDAg) were used to analyze acetylation of HDAg in metabolic labeling experiments. H7-SHDAg cells and its parental HuH-7 cells were incubated with [ 3 H]acetate briefly and their lysates were subsequently subjected to immunoprecipitation with an anti-HDAg monoclonal antibody. As shown in Fig. 1 , a [ 3 H]labeled 24-kDa protein was specifically immunoprecipitated from cell lysates of H7-SHDAg (Fig. 1A , lane 1). No such a protein could be immunoprecipitated from the lysates of parental HuH-7 cells (Fig. 1A, lane 2) . This 24-kDa band could also be recognized by a human anti-HDAg antibody (Fig. 1C, lane 1) . These results indicated that S-HDAg was acetylated in vivo.
We also examined acetylation of L-HDAg and S-HDAg by a transient transfection system. As shown in Fig. 1B , S-HDAg expressed in HuH-7 cells was acetylated (Fig. 1B , lane 1). Meanwhile, a [ 3 H]-labeled 27-kDa protein could be specifically detected in cells expressing L-HDAg (Fig. 1B , lane 2). This 27-kDa protein was recognized by a human anti-HDAg antibody by Western blotting analysis (Fig. 1D , lane 2). These results indicated that L-HDAg was also acetylated in vivo. It was noteworthy that the labeling intensity of L-HDAg was weaker than that of S-HDAg ( Fig. 1B ).
S-HDAg is acetylated in vitro by p300
There are several histone acetyltransferases (HAT) identified in human cells. These proteins, including p300/CBP, PCAF, TAFII 250 etc., have been demonstrated to acetylate histones as well as a wide spectrum of cellular and viral factors. Therefore, we tested whether p300 was able to acetylate S-HDAg. The recombinant protein corresponding to the p300 HAT domain was expressed in E. coli. Its enzymatic activity was verified by the [ 14 C]acetyl coenzyme A (acetyl CoA) exchange reaction with core histones H2A, H2B, H3, and H4 as substrates (data not shown). As shown in Fig. 2A , the in vitro acetylation experiment demonstrated that recombinant full-length S-HDAg (FL) could be acetylated by the p300 HAT domain ( Fig. 2A, lane 1) .
To define the acetylated sites on HDAg, S-HDAg protein variants harboring N-terminal 1-88 amino acids (NdAg) and 89 -195 amino acids (CdAg), respectively, were used as substrates for in vitro acetylation assay. As shown in Fig.   2A , the 15-kDa NdAg was acetylated by p300 HAT (Fig. 2A , lane 3). On the other hand, no specific signal appeared when using CdAg as the substrate ( Fig. 2A , lanes 5 and 6). Acetylation of these recombinant S-HDAg variants was not detected in the absence of the p300 HAT protein, indicating that acetylation of S-HDAg in this reaction was specifically catalyzed by the p300 HAT ( Fig. 2A , lanes 2, 4, 6). Taken together, these results suggest that p300 catalyzed the acetylation of HDAg and the acetylated targets were primarily located within the N-terminal 88 amino acid residues.
A direct association between S-HDAg and p300 CBP/p300 acetylates and interacts with several structurally unrelated cellular and viral factors (for reviews see Chan and La Thangue, 2001; Goodman and Smolik, 2000) . In the current study, we had demonstrated that HDAg was an acetylated protein and could be a substrate of p300. We further tested the interaction between these two proteins. As shown in Fig. 3 , GST fusion proteins harboring N-or Cterminal portions, but not the middle portion, of p300 could pull down S-HDAg from cell extracts (Fig. 3A, lanes 2-5) . This result suggested that S-HDAg associated with p300 through its N-and C-terminal domains. 
Lys-72 on S-HDAg is acetylated by the p300 acetyltransferase
To identify the acetylation site(s) on HDAg, we performed LC/MS/MS assay to analyze acetylated S-HDAg. First, the recombinant S-HDAg was incubated with the HAT domain of p300 and [ 14 C]acetyl CoA and then subjected to digestion by endopeptidase Glu-C. The digested peptides were then analyzed by LC/MS/MS (Tsay et al., 2000; Wang et al., 2003) . One peptide, 64 GAPPAKRARTDQME 80 , was found to be highly acetylated (data not shown). It is consistent with our finding that acetylation target was primarily in the N-terminal 88 residues (Fig. 2) . This result was further corroborated by the collision-induced dissociation (CID) experiment of this acetylated peptide. As shown in Fig. 4 , the presence of a parent ion with C 2 H 2 O neutral loss (the 764.7-m/z ion) is a signature indicative of an acetylated peptide. Furthermore, the masses of y7 to y12 ions as well as a4 to b7 deduce that Lys-72 is the acetylated residue within. 
Distinct subcellular localization of K72R mutant
To investigate the biological effects of acetylation on HDAg, HDAg mutant with a substitution of Lys-72 to Arg (K72R) was created by site-directed mutagenesis. We first analyzed the subcellular localization of the K72R mutant. As shown in Fig. 5 , the K72R mutant of S-HDAg displayed a dramatic change in its subcellular distribution pattern. While wild-type S-HDAg was predominantly in the nucleoli (Fig. 5A ), the K72R mutant was detected not only in the nucleolus but also in the cytoplasm (Fig. 5C ). Fig. 4 . Acetylation of S-HDAg at Lys-72 by p300. After in vitro acetylation assay with full-length recombinant S-HDAg and p300 HAT domain, the reaction products were digested by endoproteinase Glu-C. The resulting peptides were subjected to on-line HPLC/MS/MS. The fragment ions are denoted using the nomenclature system described by Biemann (1988) and Roepstorff and Fohlman (1984) . The average tandem mass spectrum of 785.8 m/z ion identified the peptide and the site of acetylation as the sequence shown (see Materials and methods). Because both L-HDAg and S-HDAg are predominantly in the nucleus when expressed alone or in natural HDV infection (Gowans et al., 1988; Huang et al., 2001; Macnaughton et al., 1990) , the distinct distribution pattern of K72R mutant might result from either impairing nuclear transport, reducing nuclear retention, or accelerating nuclear export, of it. To test these possibilities, cells transfected with either wild-type or mutant S-HDAg were treated with leptomycin B, an inhibitor for chromosome region maintenance 1 (CRM1)-dependent nuclear export pathway, and analyzed the subcellular localization of these S-HDAg. As shown in Figs. 5E and 5G, the cytoplasmic accumulation of K72R mutant was significantly decreased with treatment of leptomycin B (Figs. 5E and 5G). In contrast, the nucleolus and nuclear localization of wild-type S-HDAg were not affected by leptomycin B treatment (data not shown). This result suggested that the S-HDAg K72R mutant still possessed its nuclear targeting ability and the nuclear export of S-HDAg was mediated in a CRM1-dependent pathway.
Reduction of genomic RNA accumulation by K72R mutation
S-HDAg is crucial for HDV replication. Because Lys-72 mutation resulted in a redistribution of S-HDAg from the nucleus, where HDV replication takes place (Gowans et al., 1988; Taylor et al., 1987) , to the cytoplasm, we further characterize the effect of this redistribution on HDV RNA replication. A cDNA transfection system was used to examine HDV replication (Wang et al., 1994) . Plasmids carrying cDNA dimer of the HDV genome with or without K72R mutation were used in this transfection experiment. As shown in Fig. 6A , the amount of genomic RNA (G RNA) containing K72R mutation (2G 72 ) was less (Fig. 6A , lanes 4 -6) than that of the wild-type (2G WT ) (Fig. 6A, lanes  1-3) by 2-3-folds. Notably, the antigenomic RNA (AG RNA) from the wild-type and K72R mutant showed similar intensity (Fig. 6C, lanes 1 -3 vs. lanes 4 -6) . Similar experiments with plasmids carrying cDNA dimer of the wild-type (2AG WT ) or mutant (2AG 72 ) HDV antigenome as the Fig. 6 . Functional assay of the S-HDAg K72R mutant. The wild-type dimer of HDV-pCD2G, pCD2AG (indicated as 2G WT , 2AG WT ), and Lys-72 dimer mutants, pCD2G 72 and pCD2AG 72 (indicated as 2G 72 , 2AG 72 ), were transfected into HuH-7 cells, respectively. HDV RNA and HDAg were examined on days 6, 9, and 12 posttransfection (indicated as D6, D9, D12) (see Materials and methods). For detection of the RNA production from 2G WT and 2G 72 , genomic RNA and antigenomic RNA were analyzed by Northern blotting and are shown in panels A and C, respectively. For detection of the RNA production from 2AG WT and 2AG 72 , antigenomic RNA and genomic RNA were also analyzed by Northern blotting and are shown in panels B and D, respectively. The expression of both forms of HDAg from these dimer constructs was analyzed by Western blot and is shown in panels E and F. templates were also performed. As shown in Fig. 6B , the amount of antigenomic RNA was about equivalent for both clones (Fig. 6B, lanes 1 -3 vs. lanes 4-6) . However, the genomic RNA (G RNA) from the K72R mutant was reduced by 4-5-folds when compared with that from the wild-type (Fig. 6D, lanes 4-6) . These results indicated that K72R mutation on HDAg did not affect antigenomic RNA accumulation, whereas it dramatically decreased the accumulation of genomic RNA. Based on these findings, Lys72 of HDAg appeared to be crucial in the modulation of HDAg functions on genomic RNA accumulation.
Earlier appearance of L-HDAg during K72R mutant genome replication L-HDAg appears in the late stage of HDV replication through the process of RNA editing. In this study, we noticed that L-HDAg with K72R mutation appeared earlier as compared to that of the wild type. When using the wild-type HDV genome cDNA (2G WT ) in transfection experiments, L-HDAg was detected at day 9 posttransfection ( Figs. 6E and 6F, lane 2) . Intriguingly, for HDV with K72R mutation (2G 72 ), the L-HDAg was detected earlier at day 6 posttransfection ( Figs. 6E and 6F, lane 4) . Furthermore, cells transfected with cDNA of the HDV antigenome bearing K72R mutation (2AG 72 ) also showed similar earlier appearance of L-HDAg when compared with cells transfected with wild-type antigenome cDNA (2AG WT ). These results suggested that the lack of acetylation at Lys-72 of HDAg favors earlier accumulation of L-HDAg.
Discussion
In this study, we have identified a previously unrecognized posttranslational modification, acetylation, on HDAg in vivo and in vitro. Lys-72 of S-HDAg was identified as the acetylation site by LC/MS/MS. However, we cannot exclude the possibility of the existence of other acetylation sites. Furthermore, p300 HAT acetylated recombinant HDAg in vitro (Fig. 2 ), suggesting that p300 is the enzyme responsible for HDAg acetylation in vivo. CBP/p300 proteins participate in many physiological processes. They modulate functions of cellular and viral proteins by catalyzing acetylation of these factors (for reviews see Chan and La Thangue, 2001; Goodman and Smolik, 2000; Janknecht, 2002) . Because there are several cellular acetyltransferases in mammalian cells, further experiments to define the acetyltransferase(s) responsible for HDAg acetylation in vivo are still required.
HDAg interacted with p300 in vitro through the Nterminal and C-terminal portions of p300 (Fig. 3) . A wide variety of cellular and viral proteins have also been identified to interact with CBP/p300 through these two regions (for reviews see Chan and La Thangue, 2001; Goodman and Smolik, 2000 ; and the references therein). These regions encompass the conserved CH1 and KIX domains in the Nterminal and CH3 domain in the C-terminal portions of CBP/p300 (Fig. 3C) . Notably, several CBP/p300-associated proteins, such as E1A, p53, and YY1, interact with more than one of these different conserved domains.
The S-HDAg K72R mutant displayed a different subcellular distribution pattern from that of the wild type (Fig. 5) . Notably, amino acids 68-88 of HDAg had been identified as the bipartite NLS (Chang et al., 1992; . Acetylation of several cellular proteins had been demonstrated to affect their nucleocytoplasmic shuttling abilities. For example, nuclear accumulations of cellular factors CIITA and HNF4 are increased when they are acetylated at Lys residues in the NLS (Soutoglou et al., 2000; Spilianakis et al., 2000) . These results suggest that acetylation at K72 of HDAg modulates its nuclear localization.
Treatment with leptomycin B led to the redistribution of the majority of S-HDAg K72R mutant to the nucleoplasm and nucleoli (Fig. 5 ). This result indicates that the CRM1dependent pathway is involved in the nuclear export of S-HDAg, different from that of L-HDAg . HDV genomic RNA is preferentially exported from the nucleus after synthesis and processing in a CRM1-independent pathway and L-HDAg is not essential for this export process . Our current result suggests that the nuclear export of genomic RNA may proceed without S-HDAg because they are in different export pathways.
K72R mutant resulted in the reduction of HDV genomic RNA accumulation and earlier appearance of L-HDAg in the HDV life cycle (Fig. 6 ). Considering that HDAg is essential for the import of HDV RNA to the nucleus, where host RNA polymerase II produces the genomic RNA Moraleda and Taylor, 2001) , the less accumulation of HDV genomic RNA is likely due to the predominantly cytoplasmic distribution of the K72R mutant. Furthermore, the poor nuclear retention of the S-HDAg K72R mutant may also explain the earlier appearance of L-HDAg because HDAg inhibits HDV RNA editing, which results in production of L-HDAg, occurring in the nucleus (Polson et al., 1998; Wong and Lazinski, 2002) . This speculation is further supported by the finding that introduction of adenosine deaminase (ADAR) to increase HDV RNA editing also resulted in the earlier appearance of L-HDAg and less accumulation of HDV genomic RNA (Jayan and Casey, 2002) .
Many proteins undergo posttranslational modifications via well-defined mechanisms such as acetylation, phosphorylation, and methylation. These modifications control a spectrum of biochemical processes. Different modifications of HDAg possibly generate synergistic or antagonistic effects on the properties of HDAg and in turn dictate modulation of HDV life cycle. Further studies are still required to advance our understanding on the properties and functions of HDAg in the HDV life cycle.
Materials and methods
Plasmid construction
pCD2G contains a tandem dimer of wild-type HDV cDNA (1.7 kb XbaI fragment, genomic sense) with sequences derived from pSVLD3 (Kuo et al., 1989) . This construct transcribed HDV genomic RNA (G RNA) under the control of CMV immediate -early promoter (pCMV-2) (Wang et al., 1994) . pCD2AG, like pCD2G, also contains the HDV cDNA dimer but in a different orientation; therefore, pCD2AG transcribed antigenomic HDV RNA (AG RNA) driven by the CMV promoter. Both constructs could express both S-HDAg and L-HDAg, and direct HDV RNA replication. pCD2G 72 and pCD2AG 72 are similar to wild-type pCD2G and pCD2AG but with a Lys to Arg mutation at Lys-72 in HDAg ORF. pCDAg-S and pCDAg-L contained HDAg ORF and expressed S-HDAg and L-HDAg, respectively (Mu et al., 2001) . For expressing recombinant full-length S-HDAg, HDV cDNAs were amplified by PCR with the BamHI site at the end of both primers (5V-GGATCCAAGCT-TATGAGCCGGTCCGAGTCG-3V and 5V-GGATCCC-TATGGAAATCCCTGGTTTC-3V). The PCR product was digested with BamHI and subcloned into the BamHIdigested vector pET-15a (Novagene). Plasmids for recombinant protein expressing N-terminal 1-88 aa (NdAg) and Cterminal 89 -195 aa (CdAg) were gifts from Dr. H.N. Wu (Huang and Wu, 1998) .
Site-directed mutagenesis of S-HDAg
Site-directed mutagenesis was performed by Transformer Site-Directed Mutagenesis Kit (Clontech, CA). The mutagenic primers used in site-directed substitution of Lys-72 are K72R, 5V-CCCCCGGCGAḠ GAGGGCCCG-3V (underlined G is the mutated nucleotide). After synthesizing the second strand by T4 DNA polymerase, plasmids containing unmutated plasmids were removed by KpnI digestion. The DNA isolated from pooled transformants was subjected to a second round of KpnI digestion, and the second transformation was used to amplify and clone the mutated plasmids. Every mutant clone was confirmed by sequence analysis. The Lys-72 substituted mutant was designated K72R.
DNA transfection
For in vivo acetylation assay, DNA transfection was performed by lipofectamine 2000 (Gibco BRL Life Technologies) according to the manufacturer's instruction. Briefly, 1 day before transfection, HuH-7 cells were seeded onto a 60-mm diameter dish with 90% confluence in 10% FBS/ DMEM. For transfection, 40 Al of lipofectamine 2000 was diluted into 0.5 ml opti-MEM (Gibco BRL Life Technologies) and incubated at room temperature for 5 min. Indicated plasmids (10 Ag) were diluted into 0.5 ml opti-MEM. The diluted DNA was then combined with diluted lipofectamine 2000 and incubated at room temperature for 20 min. After the culture medium was replaced by 0.5 ml of opti-MEM, the DNA -liposome complexes were added to HuH-7 cells. After a 6-h incubation, the medium was removed and replaced by 10% FBS/DMEM. For indirect immunofluorescence, DNA transfection was performed by electroporation (Electro Cell Manipulator ECM 600, BTX). HuH-7 cells were trypsinized and washed with serum-free medium. Cells (4 Â 10 6 ) together with 20 Ag of DNA were suspended in 400 Al of serum-free medium and then loaded into a 4-mm gap cuvette. After charging with 150 V for 70 ms (Desired Field Strength is 375 V/cm), cells were plated onto four coverslips (22 Â 22 mm) in the presence of 10% FBS/ DMEM. For leptomycin B treatment, 2 ng/ml of LMB was added in the medium while plating.
In vivo acetylation
HuH-7 cells were transfected with plasmids expressing S-HDAg or L-HDAg. Forty-eight hours after transfection, 1 mCi/ml [ 3 H]sodium acetate (TRK12, Amersham Pharmacia Biotech, England) was added to metabolically label the acetylated protein for 90 min. The cells were then lysed in RIPA buffer and supernatants collected from 10 plates were immunoprecipitated by the standard method as described in detail elsewhere (Mu et al., 1999) . The immunopurified proteins were solubilized with SDS-PAGE sample buffer and resolved on 12% SDS-polyacrylamide gels. Gels containing [ 3 H]acetate-labeled HDAg were fixed with 10% glacial acetic acid and 45% methanol for 30 min and enhanced with a commercial fluorography enhancing solution (Amplify, Amersham Pharmacia Biotech) for 30 min. Gels were then dried and subjected to autoradiography at À70 jC for 14 days.
Western blot analysis
For the detection of immunoprecipitated HDAg's in in vivo acetylation assay, proteins were subjected to electrophoresis in a 12% SDS-polyacrylamide gel, followed by Western blot procedure as described in detail elsewhere (Mu et al., 1999) . HDAg were detected by ECL Western blot detection system (Amersham Pharmacia Biotech) with a human polyclonal antibody against HDAg's. For detection of protein from whole cell lysates, 50 Ag of protein was subjected to Western blot and detected with D9-3, a monoclonal antibody against HDAg (Mu et al., 1999) .
Purification of recombinant p300 HAT and S-HDAg
For expression of recombinant p300 HAT domain (nt. 1195-1673) , the pET-28c-p300 HAT at its native state was expressed in E. coli BL21(DE3) and purified with the Ni-NTA agarose column (Qiagen GmbH, Germany) according to the manufacturer's instructions. Briefly, cell pellets from 600-ml culture were lysed in 5 ml/g lysis buffer containing 50 mM NaH 2 PO 4 , pH 8.0, 300 mM NaCl, 10 mM imidazole, and 10 mM 2-mercaptoethanol. After sonication, lysates were bound with Ni-NTA agarose and followed by washing twice with three column volumes of wash buffer containing 50 mM NaH 2 PO 4 pH 8.0, 300 mM NaCl, 20 mM imidazole, and 10 mM 2-mercaptoethanol. Finally, the recombinant protein was eluted with elution buffer containing 50 mM NaH 2 PO 4 pH 8.0, 300 mM NaCl, 250 mM imidazole, and 10 mM 2-mercaptoethanol. Fractions containing recombinant proteins were stored at À70 jC.
For expression of recombinant S-HDAg in bacterial system, full-length S-HDAg and in a denatured form were expressed in Epicurian coli BL21-CodonPlus (DE3)-RP (Stratagene) and affinity purified with Ni-NTA agarose (Qiagen GmbH, Germany) according to the manufacturer's protocol. Briefly, cell pellets from 1000ml culture were lysed in 5 ml/g buffer B containing 8 M urea, 100 mM NaH 2 PO 4 , and 10 mM Tris -HCl, pH 8.0. After sonication, lysates were loaded onto the Ni-NTA agarose column and followed by washing twice with four column volumes of buffer C containing 8 M urea, 100 mM NaH 2 PO 4 , and 10 mM Tris-HCl, pH 6.3. Finally, the recombinant protein was eluted with elution buffer containing 8 M urea, 100 mM NaH 2 PO 4 , and 10 mM Tris -HCl, pH 5.9. Fractions containing recombinant proteins were dialyzed in PBS and stored at À70 jC. The purified NdAg was a gift from Dr. H. N. Wu (Huang and Wu, 1998) .
In vitro acetylation assay
Purified recombinant p300 HAT was incubated with purified His-S-HDAg for 60 min at 30 jC in a 40-Al reaction l reaction buffer containing 50 mM Tris -HCl pH 8.0, 10% glycerol, 0.1 mM EDTA, 1 mM DTT, and 0.2 ACi of [ 14 C]acetyl-CoA (CFA729, Amersham Pharmacia Biotech). Proteins were then resolved by SDS-PAGE. Gels containing [ 14 C]acetyl-labeled recombinant S-HDAg were fixed with 10% glacial acetic acid and 45% methanol for 30 min and enhanced with a commercial fluorography enhancing solution (Amplify, Amersham Pharmacia Biotech) for 30 min. Gels were then dried and subjected to autoradiography at À70 jC for 1 day.
GST pull down assay
Three GST-p300 plasmids were constructed by fusing the p300 open reading frame harboring amino acids 1 -596 (Nterminus), 744-1571 (middle), and 1572-2370 (C-terminus) in-frame with the GST protein gene in pGEX-2TK vector (Amersham Pharmacia Biotech). These three plasmids were gifts from Dr. David Livingston (Lee et al., 1995) . GST-p300 fusion proteins were expressed and purified according to manufacturer's instruction. H7-SHDAg cells, which stably express S-HDAg, were lysed in RIPA buffer described above for 20 min. Cell lysates prepared from H7-SHDAg cells were incubated for 2 h with various GST-p300 fusion proteins coupled to GST-sepharose 4B (Amersham Pharmacia Biotech). The beads were washed with RIPA buffer three times and were eluted with Laemmli sample buffer. Following Western blotting, S-HDAg was detected by anti-HDAg monoclonal antibodies (D9-3) and various p300 fusion proteins were detected by the anti-GST antisera (Amersham Pharmacia Biotech).
Digestion of S-HDAg protein
The solution containing in vitro acetylated S-HDAg was desalted and concentrated using a methanol -chloroformwater precipitation method (Wessel and Flugge, 1984) . Briefly, to the solution, 4 volumes of methanol and 1 volume of chloroform were sequentially added. After addition with 3 volumes of water, the mixture was centrifuged at 10 000 Â g for 15 min. The upper phase was removed and three more volumes of methanol were added. The protein was pelletted by centrifugation at 10 000 Â g for 15 min. The pellet was air dried and then resolubilized in 9 M urea. The reaction was initiated by adding 25 mM of NH 4 HCO 3 containing 50 ng of Glu-C (Promega). After a 5-h incubation at 25 jC, the reaction was stopped by freezing at À20 jC.
Mass spectrometric analysis
Electrospray mass spectrometry was performed primarily using the method described previously (Tsay et al., 2000; Wang et al., 2003) . Finnigan Mat LCQ ion trap mass spectrometer interfaced with an ABI 140D HPLC (Perkin-Elmer) was used. A 150 Â 0.5 mm PE Brownlee C18 column (Perkin-Elmer) (5-mm particle diameter, 300-Å pore size) with mobile phases of 0.1% formic acid in water (solution A) and 0.1% formic acid in acetonitrile (solution B) was used. The peptides were eluted at a flow rate of 5 Al/ min with an acetonitrile gradient, which consisted of 5-20% solution B in 20 min and 20-65% solution B in 40 min. The spectra for the eluate were acquired as successive sets of three scan modes, including MS scan, zoom scan, and MS/MS scan. The MS scan determined the intensity of the ions in the m/z range of 395-1605, the zoom scan examined the charge number of the selected ion, and the MS/MS scan acquired the CID spectrum (CID spectrum or MS/MS spectrum) of the selected ion. In the first analysis, the most abundant ion in an MS spectrum was selected for the latter scans; in the second analysis, only the ions with m/ z values corresponding to the potential acetylated peptides were selected for the CID experiment.
The acquired CID spectra were initially interpreted using the SEQUEST Browser (Finnigan, USA), which automatically correlated the MS/MS spectrum with the amino acid sequence of S-HDAg protein. No enzyme was specified during the sequence search, which could increase the confidence of identification when matched peptides had cleavage sites at Glu or Asp. A 44-Da tag, the mass of [ 14 C] acetyl group, was optionally added at Lys residue for identification of the acetylated residues. Those MS/MS scans that matched with the peptide sequences with appropriate cleavage sites were considered significant and were also subjected to manual evaluation to confirm the SEQUEST results. Specific ion chromatograms were plotted using the in-house software.
Indirect immunofluorescence
HuH-7 cells that transiently expressed WT or K72R S-HDAg were grown on rat tail-coated coverslips and fixed by 3.7% paraformaldehyde for 20 min at room temperature. After extracting with CSK buffer (50 mM NaCl, 300 mM sucrose, 10 mM Pipes pH 6.8, 3 mM MgCl 2 , 0.5% Triton X-100) for 5 min, cells were blocked in PBS containing 1% BSA, 10% goat serum, and 50 mM NH 4 Cl for 1 h at room temperature. Cells were immunostained with anti-HDAg monoclonal antibody, D9-3, for 1 h at room temperature followed by incubating with FITC-conjugated anti-mouse secondary antibody (Jackson) for another 1 h. The coverslips were mounted on a glass slide with a Vectashield (Vector Laboratory, Inc., Burlingame, CA) and observed in a confocal laser scanning microscope (Leica TCS SP2).
Northern blot analysis
Total RNAs were isolated from transfected HuH-7 cells using the RNAzolB solution following the procedure described by the manufacturer (Tel-Test, Inc). Transfected cells were washed with cold PBS twice and lysed with 1 ml RNAzolB solution/60 mm dish. After adding 0.2 ml of chloroform and incubating on ice for 15 min, the lysate was centrifuged at 12 000 rpm for 20 min at 4 jC. The RNA was in the aqueous phase and precipitated by adding equal volumes of isopropanol. Northern blotting for the detection of HDV RNA was resolved by electrophoresis following the glyoxal -dimethyl sulfoxide (DMSO) method (McMaster and Carmichael, 1977) . Total RNA (10 Ag) was mixed with 20 Al glyoxal solution and electrophoresed at 100 V for about 2 h. The gel was then electrotransferred to a membrane (Nytran, Schleicher and Schuell, Germany) with 0.25Â TAE (Tris -acetate/EDTA, 10 mM Tris -acetate, 0.25 mM EDTA) at 90 V for 1.5 h. The membrane was then cross-linked and hybridized with strand-specific riboprobes (synthesized by in vitro transcription) (Mu et al., 1999) .
